Table 5.
Physical findings and patient‐reported outcomes at 12 months post‐treatment.
| ESWT group (n = 14) | Control group (n = 13) | p Value | |
|---|---|---|---|
| ROM extensiona (°) | −0.7 ± 1.8 | −2.3 ± 3.3 | n.s. |
| ROM flexion a (°) | 137.5 ± 7.8 | 136.2 ± 3.6 | n.s. |
| Patellar floating | 1 (7%) | 1 (8%) | n.s. |
| McMurray test | 1 (7%) | 5 (38%) | n.s. |
| IKDC a | 75.3 ± 13.5 | 65.5 ± 14.8 | n.s. |
| Lysholm score a | 90.6 ± 10.6 | 86.4 ± 16.0 | n.s. |
| KOOS | |||
| Symptoms a | 91.8 ± 11.9 | 86.1 ± 12.7 | n.s. |
| Pain a | 92.3 ± 10.4 | 85.5 ± 12.2 | n.s. |
| ADL a | 95.8 ± 6.2 | 93.7 ± 9.2 | n.s. |
| Sports/Rec a | 79.3 ± 25.3 | 73.5 ± 22.2 | n.s. |
| QOL a | 72.3 ± 22.0 | 68.8 ± 23.0 | n.s. |
Abbreviations: ADL, activities of daily living; ESWT, extracorporeal shockwave therapy; IKDC, International Knee Documentation Committee; KOOS, knee injury and osteoarthritis outcome score; n.s., not significant; QOL, quality of life; ROM, range of motion.
a
Values are presented as mean ± SD.